{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:33:07Z","timestamp":1790375587993,"version":"4.1.0"},"reference-count":27,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adult T-cell leukemia\/lymphoma (ATLL) in Japan presents at a median age of 70 years and only 5% of patients are &amp;lt;50 years of age. We conducted RNA and targeted DNA sequencing of 8 ATLLs from Japanese patients &amp;lt;50 years of age and identified 3 (37.5%) with both CTLA4-CD28 and inducible costimulator (ICOS)-CD28 fusions. Mutations of PLCG1, PRKCB, and STAT3, which were frequent in other ATLL-sequencing studies, were not identified. Differential expression analysis identified the negative checkpoint molecule LAG3 as the most downregulated gene among cases with the fusions. Immunohistochemistry demonstrated expression of CD80 and CD86, the ligands for CTLA4 and CD28, on ATLL cells and tumor-associated macrophages, respectively. Expression of CTLA4-CD28 in Ba\/F3 cells conferred cytokine-independent growth when cocultured with Raji cells that express CD80 and CD86. Growth was associated with recruitment of the p85 subunit of phosphatidylinositol 3-kinase to CTLA4-CD28 and phosphorylation of AKT and extracellular signal-regulated kinase. A CTLA4-blocking antibody reduced cytokine-independent growth in a dose-dependent manner. Together, these results suggest that young Japanese ATLL cases have a unique biology dependent on cell-nonautonomous interactions that drive CD28 signaling. Assessment for CD28 fusions and treatment with CTLA4 blockade should be considered in younger patients with relapsed\/refractory ATLL.<\/jats:p>","DOI":"10.1182\/blood.2019001815","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T20:49:35Z","timestamp":1579639775000},"page":"1467-1471","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions"],"prefix":"10.1182","volume":"135","author":[{"given":"Noriaki","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan;"},{"name":"Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9682-4164","authenticated-orcid":false,"given":"Kay","family":"Shigemori","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Donaldson","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Trevisani","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A.","family":"Cordero","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Stevenson","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Bu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Arakawa","sequence":"first","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"first","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Yoda","sequence":"first","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Y.","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-3907","authenticated-orcid":false,"given":"David M.","family":"Weinstock","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"21","key":"2020042311585051700_B1","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1158\/0008-5472.CAN-14-0643","article-title":"Molecular characterization of chronic-type adult T-cell leukemia\/lymphoma","volume":"74","author":"Yoshida","year":"2014","journal-title":"Cancer Res"},{"issue":"11","key":"2020042311585051700_B2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"7607","key":"2020042311585051700_B3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"2","key":"2020042311585051700_B4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2020042311585051700_B5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2017-11-815472","article-title":"Clinicogenetic risk modeling in ATL","volume":"131","author":"Yoshida","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2020042311585051700_B6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1349-7006.1989.tb02289.x","article-title":"Multi-step carcinogenesis model for adult T-cell leukemia","volume":"80","author":"Okamoto","year":"1989","journal-title":"Jpn J Cancer Res"},{"issue":"12","key":"2020042311585051700_B7","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: a nationwide survey","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci"},{"issue":"11","key":"2020042311585051700_B8","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1002\/cam4.1805","article-title":"Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification","volume":"7","author":"Muto","year":"2018","journal-title":"Cancer Med"},{"issue":"7153","key":"2020042311585051700_B9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"2020042311585051700_B10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fonc.2014.00054","article-title":"Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"4","author":"Bernt","year":"2014","journal-title":"Front Oncol"},{"key":"2020042311585051700_B11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41467-018-04356-9","article-title":"Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models","volume":"9","author":"Ng","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"2020042311585051700_B12","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2017.186767","article-title":"RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells","volume":"103","author":"Vallois","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"2020042311585051700_B13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2020042311585051700_B14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"2020042311585051700_B15","doi-asserted-by":"crossref","first-page":"e49201","DOI":"10.1371\/journal.pone.0049201","article-title":"Next-generation cDNA screening for oncogene and resistance phenotypes","volume":"7","author":"Shindoh","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"2020042311585051700_B16","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.4049\/jimmunol.1301240","article-title":"Cutting edge: a double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression","volume":"192","author":"Boomer","year":"2014","journal-title":"J Immunol"},{"issue":"4","key":"2020042311585051700_B17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/1074-7613(95)90171-X","article-title":"Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation","volume":"3","author":"Cai","year":"1995","journal-title":"Immunity"},{"issue":"6332","key":"2020042311585051700_B18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"issue":"6","key":"2020042311585051700_B19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3324\/haematol.2015.139253","article-title":"Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma","volume":"101","author":"Yoo","year":"2016","journal-title":"Haematologica"},{"issue":"5","key":"2020042311585051700_B20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"2020042311585051700_B21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat Immunol"},{"issue":"12","key":"2020042311585051700_B22","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","article-title":"FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma","volume":"19","author":"Roncador","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"2020042311585051700_B23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol"},{"key":"2020042311585051700_B24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/asheducation-2018.1.63","article-title":"Challenges and implications of genomics for T-cell lymphomas","volume":"2018","author":"Jacobsen","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2020042311585051700_B25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mgg3.121","article-title":"Personalized treatment of S\u00e9zary syndrome by targeting a novel CTLA4:CD28 fusion","volume":"3","author":"Sekulic","year":"2015","journal-title":"Mol Genet Genomic Med"},{"issue":"8","key":"2020042311585051700_B26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood-2017-08-802470","article-title":"Activity of the PI3K-\u03b4,\u03b3 inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma","volume":"131","author":"Horwitz","year":"2018","journal-title":"Blood"},{"key":"2020042311585051700_B27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40364-018-0138-7","article-title":"Phosphatidylinositol 3-kinase-\u03b4 (PI3K-\u03b4) is a potential therapeutic target in adult T-cell leukemia-lymphoma","volume":"6","author":"Katsuya","year":"2018","journal-title":"Biomark Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/17\/1467\/1724694\/bloodbld2019001815.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/17\/1467\/1724694\/bloodbld2019001815.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T15:59:17Z","timestamp":1587657557000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/17\/1467\/431273\/Genomic-landscape-of-young-ATLL-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":27,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,4,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019001815","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]}}}